Suppr超能文献

孕期及出生后早期的甲基黄嘌呤。

Methylxanthines during pregnancy and early postnatal life.

作者信息

Adén Ulrika

机构信息

Department of Woman and Child Health, Karolinska Institute, Stockholm, Sweden.

出版信息

Handb Exp Pharmacol. 2011(200):373-89. doi: 10.1007/978-3-642-13443-2_14.

Abstract

World-wide, many fetuses and infants are exposed to methylxanthines via maternal consumption of coffee and other beverages containing these substances. Methylxanthines (caffeine, theophylline and aminophylline) are also commonly used as a medication for apnea of prematurity.The metabolism of methylxanthines is impaired in pregnant women, fetuses and neonates, leading to accumulating levels thereof. Methylxanthines readily passes the placenta barrier and enters all tissues and thus may affect the fetus/newborn at any time during pregnancy or postnatal life, given that the effector systems are mature.At clinically relevant doses, the major effector system for methylxanthines is adenosine receptors. Animal studies suggest that adenosine receptors in the cardiovascular, respiratory and immune system are developed at birth, but that cerebral adenosine receptors are not fully functional. Furthermore animal studies have shown protective positive effects of methylxanthines in situations of hypoxia/ischemia in neonates. Similarly, a positive long-term effect on lung function and CNS development was found in human preterm infants treated with high doses of caffeine for apneas. There is now evidence that the overall benefits from methylxanthine therapy for apnea of prematurity outweigh potential short-term risks.On the other hand it is important to note that experimental studies have indicated that long-term effects of caffeine during pregnancy and postnatally may include altered behavior and altered respiratory control in the offspring, although there is currently no human data to support this.Some epidemiology studies have reported negative effects on pregnancy and perinatal outcomes related to maternal ingestion of high doses of caffeine, but the results are inconclusive. The evidence base for adverse effects of caffeine in first third of pregnancy are stronger than for later parts of pregnancy and there is currently insufficient evidence to advise women to restrict caffeine intake after the first trimester.

摘要

在全球范围内,许多胎儿和婴儿通过母亲饮用咖啡及其他含有甲基黄嘌呤的饮料而接触到这些物质。甲基黄嘌呤(咖啡因、茶碱和氨茶碱)也常用于治疗早产儿呼吸暂停。孕妇、胎儿和新生儿的甲基黄嘌呤代谢受损,导致其体内水平不断累积。甲基黄嘌呤很容易穿过胎盘屏障并进入所有组织,因此在孕期或出生后的任何时候都可能影响胎儿/新生儿,前提是效应系统已经成熟。在临床相关剂量下,甲基黄嘌呤的主要效应系统是腺苷受体。动物研究表明,心血管、呼吸和免疫系统中的腺苷受体在出生时就已发育,但脑内腺苷受体尚未完全发挥功能。此外,动物研究还显示甲基黄嘌呤在新生儿缺氧/缺血情况下具有保护性积极作用。同样,在接受高剂量咖啡因治疗呼吸暂停的人类早产儿中,发现对肺功能和中枢神经系统发育有积极的长期影响。现在有证据表明,甲基黄嘌呤治疗早产儿呼吸暂停的总体益处超过了潜在的短期风险。另一方面,需要注意的是,实验研究表明,孕期和产后咖啡因的长期影响可能包括后代行为改变和呼吸控制改变,尽管目前尚无人类数据支持这一点。一些流行病学研究报告了母亲摄入高剂量咖啡因对妊娠和围产期结局的负面影响,但结果尚无定论。孕期前三个月咖啡因产生不良影响的证据比孕期后期更强,目前没有足够的证据建议女性在孕早期后限制咖啡因摄入量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验